9.52
price down icon5.84%   -0.59
 
loading
前日終値:
$10.11
開ける:
$10.24
24時間の取引高:
655.45K
Relative Volume:
0.67
時価総額:
$806.11M
収益:
-
当期純損益:
$-106.81M
株価収益率:
-2.8747
EPS:
-3.3117
ネットキャッシュフロー:
$-8.40M
1週間 パフォーマンス:
-8.46%
1か月 パフォーマンス:
-6.39%
6か月 パフォーマンス:
-37.37%
1年 パフォーマンス:
-56.75%
1日の値動き範囲:
Value
$9.51
$10.47
1週間の範囲:
Value
$9.51
$10.68
52週間の値動き範囲:
Value
$8.97
$30.96

Immunome Inc Stock (IMNM) Company Profile

Name
名前
Immunome Inc
Name
セクター
Healthcare (1169)
Name
電話
610-321-3700
Name
住所
18702 N. CREEK PARKWAY, BOTHELL
Name
職員
105
Name
Twitter
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
IMNM's Discussions on Twitter

IMNM を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
IMNM
Immunome Inc
9.52 806.11M 0 -106.81M -8.40M -3.3117
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.24 124.35B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
700.33 76.56B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
644.48 39.16B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
250.59 32.44B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
BNTX
Biontech Se Adr
120.01 28.77B 3.30B -501.07M 1.03B -2.1146

Immunome Inc Stock (IMNM) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-11-08 開始されました Stephens Overweight
2024-05-31 開始されました Piper Sandler Overweight
2024-04-30 開始されました JP Morgan Overweight
2024-04-15 開始されました Guggenheim Buy
2024-01-29 開始されました Leerink Partners Outperform
2023-12-19 開始されました Wedbush Outperform
2021-10-29 開始されました Cantor Fitzgerald Overweight
すべてを表示

Immunome Inc (IMNM) 最新ニュース

pulisher
Feb 19, 2025

What Is Going On With Immunome Inc (NASDAQ: IMNM)? - Stocks Register

Feb 19, 2025
pulisher
Feb 19, 2025

Immunome CFO receives relocation package, $400K in bonuses - MSN

Feb 19, 2025
pulisher
Feb 17, 2025

Where are the Opportunities in (IMNM) - Stock Traders Daily

Feb 17, 2025
pulisher
Feb 15, 2025

Three Bridge Wealth Advisors LLC Invests $293,000 in Immunome, Inc. (NASDAQ:IMNM) - MarketBeat

Feb 15, 2025
pulisher
Feb 15, 2025

Immunome (NASDAQ:IMNM) Trading Down 6.7%Should You Sell? - MarketBeat

Feb 15, 2025
pulisher
Feb 14, 2025

Immunome (NASDAQ:IMNM) Trading Up 11.7%Here's What Happened - MarketBeat

Feb 14, 2025
pulisher
Feb 14, 2025

Q1 Earnings Forecast for Immunome Issued By Leerink Partnrs - MarketBeat

Feb 14, 2025
pulisher
Feb 11, 2025

Immunome (NASDAQ:IMNM) Stock Price Down 6.7% – Here’s What Happened - Defense World

Feb 11, 2025
pulisher
Feb 11, 2025

Philadelphia biotech firm backed by more than $130M names new CEO - The Business Journals

Feb 11, 2025
pulisher
Feb 11, 2025

Pharma Veteran Behind Immunome's Success Story Named CEO of Rising Biotech Aro - StockTitan

Feb 11, 2025
pulisher
Feb 11, 2025

Research Analysts Set Expectations for Immunome Q1 Earnings - Defense World

Feb 11, 2025
pulisher
Feb 10, 2025

Checking in on Immunome Inc (IMNM) after recent insiders movement - Knox Daily

Feb 10, 2025
pulisher
Feb 08, 2025

After The Stock Fell -1.45% Over The Week, Is Immunome Inc (NASDAQ: IMNM) Still A Buy? - Marketing Sentinel

Feb 08, 2025
pulisher
Feb 08, 2025

Immunome, Inc. (NASDAQ:IMNM) CEO Clay B. Siegall Purchases 150,000 Shares - MarketBeat

Feb 08, 2025
pulisher
Feb 08, 2025

Short Interest in Immunome, Inc. (NASDAQ:IMNM) Rises By 12.2% - MarketBeat

Feb 08, 2025
pulisher
Feb 06, 2025

Immunome Inc [IMNM] stock for 1,162,500 USD was acquired by SIEGALL CLAY B - Knox Daily

Feb 06, 2025
pulisher
Feb 06, 2025

Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Feb 06, 2025
pulisher
Feb 06, 2025

Immunome (NASDAQ:IMNM) Shares Gap Up on Insider Buying Activity - MarketBeat

Feb 06, 2025
pulisher
Feb 06, 2025

Following a 53% decline over last year, recent gains may please Immunome, Inc. (NASDAQ:IMNM) institutional owners - Simply Wall St

Feb 06, 2025
pulisher
Feb 05, 2025

Deeper Dive: Understanding Immunome Inc (IMNM) Through its Various Ratios - The Dwinnex

Feb 05, 2025
pulisher
Feb 05, 2025

Immunome (NASDAQ:IMNM) Shares Gap Up After Insider Buying Activity - Defense World

Feb 05, 2025
pulisher
Feb 04, 2025

Tuesday 2/4 Insider Buying Report: IMNM - Nasdaq

Feb 04, 2025
pulisher
Feb 04, 2025

Immunome Inc (IMNM) stock on the rise: An overview - US Post News

Feb 04, 2025
pulisher
Feb 04, 2025

Immunome (NASDAQ:IMNM) Sees Strong Trading VolumeWhat's Next? - MarketBeat

Feb 04, 2025
pulisher
Feb 03, 2025

Insider Buying: Clay Siegall Acquires 150,000 Shares of Immunome Inc (IMNM) - GuruFocus.com

Feb 03, 2025
pulisher
Feb 03, 2025

Immunome (NASDAQ:IMNM) Trading Up 7.2%Should You Buy? - MarketBeat

Feb 03, 2025
pulisher
Feb 02, 2025

Scharf Investments LLC Takes Position in Immunome, Inc. (NASDAQ:IMNM) - MarketBeat

Feb 02, 2025
pulisher
Jan 31, 2025

Immunome Closes Public Offering of Shares -January 31, 2025 at 04:13 pm EST - Marketscreener.com

Jan 31, 2025
pulisher
Jan 31, 2025

Immunome Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares - Business Wire

Jan 31, 2025
pulisher
Jan 31, 2025

Immunome announces $125 million stock offering - MSN

Jan 31, 2025
pulisher
Jan 31, 2025

Immunome Secures Massive $172.5M Capital Injection as Top Banks Rush to Join Offering - StockTitan

Jan 31, 2025
pulisher
Jan 31, 2025

Vanguard Group Inc. Reduces Stake in Immunome Inc. - GuruFocus.com

Jan 31, 2025
pulisher
Jan 30, 2025

Latham & Watkins Advises on Immunome’s Upsized Public Offering of Common Stock - Legal Desire News Network

Jan 30, 2025
pulisher
Jan 30, 2025

Immunome stock tumbles after public offering pricing - MSN

Jan 30, 2025
pulisher
Jan 30, 2025

Immunome Can Take The Fight To Competitors With Varegacestat (NASDAQ:IMNM) - Seeking Alpha

Jan 30, 2025
pulisher
Jan 30, 2025

Immunome prices upsized public offering to raise $150M - MSN

Jan 30, 2025
pulisher
Jan 30, 2025

Immunome stock tumbles after public offering pricing By Investing.com - Investing.com South Africa

Jan 30, 2025
pulisher
Jan 30, 2025

IMNMImmunome, Inc. Latest Stock News & Market Updates - StockTitan

Jan 30, 2025
pulisher
Jan 30, 2025

Immunome Prices $150 Million Stock Offering -January 30, 2025 at 03:53 am EST - Marketscreener.com

Jan 30, 2025
pulisher
Jan 30, 2025

JPMorgan Chase & Co. Acquires 1,520 Shares of Immunome, Inc. (NASDAQ:IMNM) - Defense World

Jan 30, 2025
pulisher
Jan 30, 2025

Immunome Announces Pricing of Upsized Public Offering of Common Stock - BioSpace

Jan 30, 2025
pulisher
Jan 30, 2025

Immunome Announces Proposed Public Offering of Common Stock - BioSpace

Jan 30, 2025
pulisher
Jan 29, 2025

Immunome's Massive $150M Capital Raise: Major Banks Back Biotech's Ambitious Plans - StockTitan

Jan 29, 2025

Immunome Inc (IMNM) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Immunome Inc (IMNM) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
SIEGALL CLAY B
President and CEO
Nov 21 '24
Buy
9.54
66,057
630,263
485,693
SIEGALL CLAY B
President and CEO
Nov 22 '24
Buy
9.78
33,943
331,918
519,636
Lechleider Robert
Chief Medical Officer
Nov 21 '24
Buy
9.48
15,805
149,800
15,805
Tsai Philip
Chief Technology Officer
Nov 21 '24
Buy
9.43
21,000
198,030
21,000
Rosett Max
Chief Financial Officer
Sep 19 '24
Option Exercise
1.05
42,000
44,100
61,856
Rosett Max
Chief Financial Officer
Sep 19 '24
Sale
16.01
14,380
230,224
47,476
$33.42
price up icon 0.27%
$81.06
price down icon 3.05%
$361.10
price down icon 1.70%
$22.12
price down icon 4.08%
biotechnology ONC
$255.37
price up icon 4.57%
$120.01
price up icon 1.81%
大文字化:     |  ボリューム (24 時間):